智飞生物
(300122)
| 流通市值：213.42亿 | | | 总市值：361.22亿 |
| 流通股本：14.14亿 | | | 总股本：23.94亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,709,403,271.74 | 2,625,608,880.22 | 2,497,716,557.97 | 2,566,465,559.45 |
| 衍生金融资产 | - | - | - | 2,355,610.36 |
| 应收票据及应收账款 | 10,924,650,759.8 | 11,164,680,690.33 | 12,814,026,860.33 | 13,548,329,289.66 |
| 应收账款 | 10,924,650,759.8 | 11,164,680,690.33 | 12,814,026,860.33 | 13,548,329,289.66 |
| 预付款项 | 19,392,226.56 | 23,489,323.54 | 29,748,249.18 | 28,432,594.6 |
| 其他应收款合计 | 64,472,865.63 | 148,121,404.93 | 475,804,737.8 | 11,320,897.76 |
| 存货 | 3,573,364,957.15 | 5,003,389,773.82 | 20,245,742,306.13 | 21,014,568,347.64 |
| 其他流动资产 | 126,499,252.54 | 53,812,040.16 | 50,017,710.37 | 6,018,368.22 |
| 流动资产合计 | 16,417,783,333.42 | 19,019,102,113 | 36,113,056,421.78 | 37,177,490,667.69 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 289,350,000 | 289,350,000 | 291,000,000 | 291,000,000 |
| 投资性房地产 | 228,560.1 | 242,972.22 | 272,272.73 | 315,504.46 |
| 固定资产 | 4,243,524,067.72 | 4,314,625,695.28 | 4,442,593,754.4 | 4,358,489,204.98 |
| 在建工程 | 1,504,591,955.9 | 1,547,297,845.79 | 1,512,448,742.19 | 831,511,209.77 |
| 使用权资产 | 15,825,103.17 | 17,932,590.77 | 19,482,487.3 | 20,638,561.98 |
| 无形资产 | 561,557,775.39 | 574,483,580.08 | 639,787,556.5 | 550,318,243.66 |
| 开发支出 | 2,057,369,776.42 | 2,008,970,951.72 | 1,844,020,281.43 | 1,362,412,117.73 |
| 商誉 | 19,279,096.95 | 19,279,096.95 | 19,279,096.95 | 19,279,096.95 |
| 长期待摊费用 | 79,300,024.06 | 81,328,209.15 | 88,390,432.59 | 89,139,998.55 |
| 递延所得税资产 | 3,748,495,907.76 | 3,697,299,455.48 | 1,269,808,277.64 | 1,105,305,461.62 |
| 其他非流动资产 | 154,733,675.42 | 149,804,792.69 | 175,812,961.23 | 163,760,463.67 |
| 非流动资产合计 | 12,674,255,942.89 | 12,700,615,190.13 | 10,302,895,862.96 | 8,792,169,863.37 |
| 资产总计 | 29,092,039,276.31 | 31,719,717,303.13 | 46,415,952,284.74 | 45,969,660,531.06 |
| 流动负债: | | | | |
| 短期借款 | 560,036,287.57 | 8,594,225,695.2 | 10,317,863,514.99 | 13,964,455,677.63 |
| 衍生金融负债 | - | 14,328,626.25 | 7,884,818.79 | - |
| 应付票据及应付账款 | 439,222,680.13 | 841,162,186.22 | 1,507,881,472.83 | 636,860,737.11 |
| 其中：应付票据 | - | 217,176 | - | 3,133,764 |
| 应付账款 | 439,222,680.13 | 840,945,010.22 | 1,507,881,472.83 | 633,726,973.11 |
| 预收款项 | 2,969,947.49 | 2,087,757.26 | 840,022.5 | 1,406,328.64 |
| 合同负债 | 58,940,874.26 | 83,402,880.18 | 141,464,346.89 | 14,290,268.71 |
| 应付职工薪酬 | 27,711,570.1 | 263,214,117.54 | 51,845,732.1 | 40,868,689.68 |
| 应交税费 | 20,087,099.13 | 332,793,752.65 | 175,015,898.77 | 129,054,324.76 |
| 其他应付款合计 | 618,478,162.09 | 653,967,530.39 | 623,762,193.57 | 238,571,453.66 |
| 一年内到期的非流动负债 | 2,877,816,377.8 | 774,820,535.45 | 175,412,244.3 | 150,826,079.81 |
| 其他流动负债 | 622,281,965.43 | 843,763,274.17 | 2,501,052.71 | 1,618,832.85 |
| 流动负债合计 | 5,227,544,964 | 12,403,766,355.31 | 13,004,471,297.45 | 15,177,952,392.85 |
| 非流动负债: | | | | |
| 长期借款 | 7,358,763,176.72 | 2,408,877,737.72 | 3,094,161,871.06 | 276,626,983.65 |
| 应付债券 | 499,718,411.55 | 499,691,502.25 | 499,862,625.1 | - |
| 租赁负债 | 7,842,386.6 | 9,538,260.53 | 10,886,840.59 | 12,082,249.38 |
| 递延收益 | 250,083,452.17 | 256,047,355.66 | 256,336,714.55 | 204,706,881.62 |
| 递延所得税负债 | 35,657,718.17 | 35,663,532.69 | 39,790,873.26 | 40,411,513.93 |
| 非流动负债合计 | 8,152,065,145.21 | 3,209,818,388.85 | 3,901,038,924.56 | 533,827,628.58 |
| 负债合计 | 13,379,610,109.21 | 15,613,584,744.16 | 16,905,510,222.01 | 15,711,780,021.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,393,789,747 | 2,393,789,747 | 2,393,789,747 | 2,393,789,747 |
| 资本公积 | 210,192,457.23 | 210,192,457.23 | 210,192,457.23 | - |
| 盈余公积 | 893,882,416.33 | 893,882,416.33 | 893,882,416.33 | 1,196,894,873.5 |
| 未分配利润 | 11,953,597,918.97 | 12,341,914,197.97 | 25,737,173,937.57 | 26,667,195,889.13 |
| 归属于母公司股东权益合计 | 15,451,462,539.53 | 15,839,778,818.53 | 29,235,038,558.13 | 30,257,880,509.63 |
| 少数股东权益 | 260,966,627.57 | 266,353,740.44 | 275,403,504.6 | - |
| 股东权益合计 | 15,712,429,167.1 | 16,106,132,558.97 | 29,510,442,062.73 | 30,257,880,509.63 |
| 负债和股东权益合计 | 29,092,039,276.31 | 31,719,717,303.13 | 46,415,952,284.74 | 45,969,660,531.06 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-30 | 2025-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |